http://www.sangamo.com
Sangamo Therapeutics, Inc. Company Intro
Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation. Meet the leaders and learn more about Sangamo's latest developments.
Industry
Healthcare
Sangamo Therapeutics, Inc. Headquaters
7000 Marina Boulevard
Brisbane,94005
United States
Sangamo Therapeutics, Inc. Share price
18 Jan 2021 02:31 GMT
$16.16
-0.03 (-0.19 %)
Sangamo Therapeutics, Inc. Market cap
$2.228 B
WMC RANKING
2021
Sangamo Therapeutics, Inc. # 59
BiotechnologyLatest Sangamo Therapeutics, Inc. News
08 Jan 2021
Bearish: Analysts Just Cut Their Sangamo Therapeutics, Inc ...
Bearish: Analysts Just Cut Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Revenue and EPS estimates. By: Simply Wall St. Published: January 08, 2021.
08 Jan 2021
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analysts Just ...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analysts Just Slashed Next Year's Estimates. Read full article.
08 Jan 2021
The Future Of Sangamo Therapeutics, Inc. (NASDAQ:SGMO ...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) price on Thursday, Jan 07, rose 4.99% above its previous day's close as an upside momentum from buyers ...
WMC Market Score
WMC Market to Revenue Score
Sangamo Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Sangamo Therapeutics, Inc. | USD | $111,438 | $221,636 | $-101,594 | $22,280B | 59 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,660B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,740B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $586,520B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $273,380B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Sangamo Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. Post vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Sangamo Therapeutics, Inc. | 1.21 | 5.10 | 9.43 | 0 | 0 | 0 | 7.46 |
| Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.97 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
